Evidence map›Paper›PMID 33005899›Full record

ArticleNeuro-oncology advances

Multiple metastases to the bone and bone marrow from a 1p/19q-codeleted and

Hiroyuki Shimizu, Kazuya Motomura, Fumiharu Ohka, Kosuke Aoki, Kuniaki Tanahashi, Masaki Hirano, Lushun Chalise, Tomohide Nishikawa, Junya Yamaguchi, Toshihiko Wakabayashi and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Neuro-oncology advances. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Molecularly defined oligodendroglioma evolving to osseous metastases.Journal of neuropathology and experimental neurology · 2025
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Hiroyuki ShimizuDepartment of Neurosurgery, Nagoya University School of Medicine, Nagoya, Japan.
Kazuya MotomuraDepartment of Neurosurgery, Nagoya University School of Medicine, Nagoya, Japan.ORCID 0000-0002-4376-1104
Fumiharu OhkaDepartment of Neurosurgery, Nagoya University School of Medicine, Nagoya, Japan.
Kosuke AokiDepartment of Neurosurgery, Nagoya University School of Medicine, Nagoya, Japan.
Kuniaki TanahashiDepartment of Neurosurgery, Nagoya University School of Medicine, Nagoya, Japan.
Masaki HiranoDepartment of Neurosurgery, Nagoya University School of Medicine, Nagoya, Japan.
Lushun ChaliseDepartment of Neurosurgery, Nagoya University School of Medicine, Nagoya, Japan.
Tomohide NishikawaDepartment of Neurosurgery, Nagoya University School of Medicine, Nagoya, Japan.
Junya YamaguchiDepartment of Neurosurgery, Nagoya University School of Medicine, Nagoya, Japan.
Toshihiko WakabayashiDepartment of Neurosurgery, Nagoya University School of Medicine, Nagoya, Japan.
Atsushi NatsumeDepartment of Neurosurgery, Nagoya University School of Medicine, Nagoya, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

anaplastic oligodendrogliomabone and bone marrowIDH2 mutationmultiple metastases

Identifiers

PMID33005899
PMCPMC7513887

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.